article thumbnail

Innovation as Strategy: Enabling life sciences of the Future – download the free booklet by Healthware Group

Digital Health Global

In the fast-paced world of life sciences, embracing innovation has become a top priority for companies striving to stay ahead of the curve. With digital transformation, innovation is no longer a “nice to have” but the driving force behind life sciences organizations’ success. Download the booklet

article thumbnail

Navigating Correlation and Causation with Life Sciences in the Age of AI

Healthcare IT Today

The following is a guest article by Alex Long, Head of Life Sciences Sales Strategy at Dell Technologies In science, avoiding correlation without causation is a cornerstone of research methodology. One recent example is the controversial history of clinical studies related to hormone replacement therapy (HRT).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Proceeding with Caution: The Impact of (Generative) AI on Healthcare and Life Sciences

Healthcare IT Today

The following is a guest article by Steven Lazer, Global Healthcare & Life Sciences CTO, Alex Long, Head of Life Sciences Sales Strategy, and Michael Giannopoulos, Healthcare Global CISO and CTO for the Americas at Dell Technologies. Artificial intelligence (AI) has been around for a long time.

article thumbnail

HeartMates, Bringing Community and Heart Health Love from Damar Hamlin – Abbott at #CES2024

Health Populi

Abbott, one of the first life science companies to exhibit at CES back in 2022, announced the HeartMates program here at #CES2024 today as part of a panel titled Ahead of the Game: Revolutionizing Athlete Safety with Emerging Health Tech.

article thumbnail

Lavita AI Raises $5M Seed Financing to Launch the First Patient-Driven Health Information Marketplace to Accelerate Life Sciences Innovation

Digital Health Global

Lavita platform will enable numerous applications within life science research, biopharma development, and healthcare innovation. Life science researchers can use the platform to convene data cohorts for conducting large-scale population studies such as genome-wide and phenome-wide association studies.

article thumbnail

The Patient as Prescription Drug Payer – The GoodRx Playbook

Health Populi

I collaborated with GoodRx on a “yellow paper” discussing The Health Consumers as Payer , with implications and calls-to-action for pharma and life science companies. You can download the paper at this link.

article thumbnail

Partnering Up in the Health Care Ecosystem to Drive Transformation – for Organizations and Health Consumers Alike

Health Populi

They offer the example of several health care providers coming together to contribute capital and purchase medications to bolster hospitals’ supply of scarce medicines. This last chart, from the Swiss Re report adapted from a version in a Deloitte study, diagrams examples of sensor data streaming for a patient dealing with diabetes.